Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × aldesleukin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 57 Leukemia, Myeloid, Acute 27 Leukemia 24 Lymphoma 21 Carcinoma, Renal Cell 21 Kidney Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasm Metastasis 13 Lymphoma, Mantle-Cell 12 Myelodysplastic Syndromes 11 Lymphoma, Non-Hodgkin 11 Lymphoma, Follicular 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Ovarian Neoplasms 10 Neuroblastoma 9 Multiple Myeloma 8 Lymphoma, B-Cell, Marginal Zone 8 Congenital Abnormalities 8 Breast Neoplasms 8 Recurrence 7 Lymphoma, Large B-Cell, Diffuse 7 Hodgkin Disease 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 7 Stomach Neoplasms 6 Lymphoma, Large-Cell, Immunoblastic 6 Lung Neoplasms 5 Leukemia, Myelomonocytic, Chronic 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Fallopian Tube Neoplasms 5

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡